NCT03908957View on ClinicalTrials.gov

to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

August 9, 2019

Study Completion Date

August 9, 2019

Conditions
Safety Issues
Interventions
DRUG

Ga68-Dolacga Injection

Ga68-Dolacga Injection, 3.5±0.25 mCi, single dose iv

Trial Locations (1)

10617

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Atomic Research Institute, Taiwan

OTHER

NCT03908957 - to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers | Biotech Hunter | Biotech Hunter